ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 306 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q1 2022. The put-call ratio across all filers is 1.19 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,377,517 | -25.7% | 51,266 | -1.4% | 1.78% | -20.4% |
| Q2 2023 | $1,854,677 | +40.8% | 52,010 | +0.3% | 2.23% | +22.3% |
| Q1 2023 | $1,317,701 | -64.7% | 51,878 | -43.7% | 1.83% | -49.1% |
| Q4 2022 | $3,735,373 | +46.7% | 92,095 | +19.5% | 3.59% | +46.4% |
| Q3 2022 | $2,546,000 | +10.8% | 77,049 | +18.1% | 2.45% | -2.1% |
| Q2 2022 | $2,297,000 | -43.7% | 65,239 | -26.5% | 2.50% | -11.8% |
| Q1 2022 | $4,082,000 | -46.7% | 88,749 | -23.2% | 2.84% | -22.9% |
| Q4 2021 | $7,663,000 | +16.4% | 115,580 | +9.6% | 3.68% | +25.9% |
| Q3 2021 | $6,586,000 | +2.2% | 105,491 | +35.6% | 2.92% | -1.6% |
| Q2 2021 | $6,445,000 | +33.2% | 77,815 | +6.7% | 2.97% | +3.9% |
| Q1 2021 | $4,837,000 | +30.6% | 72,948 | +51.1% | 2.86% | +1.3% |
| Q4 2020 | $3,703,000 | – | 48,265 | – | 2.82% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,328 | $51,213,000 | 30.37% |
| JOHNSON & JOHNSON | 3,260,869 | $203,576,000 | 17.86% |
| ACT CAPITAL MANAGEMENT, LLC | 194,000 | $12,111,000 | 6.28% |
| Aquilo Capital Management, LLC | 527,926 | $32,958,000 | 5.99% |
| Evolutionary Tree Capital Management, LLC | 105,491 | $6,586,000 | 2.92% |
| ACUTA CAPITAL PARTNERS, LLC | 121,500 | $7,585,000 | 2.68% |
| L1 Capital Pty Ltd | 297,915 | $18,599,000 | 2.31% |
| Avidity Partners Management LP | 673,700 | $42,059,000 | 0.93% |
| Hood River Capital Management LLC | 338,734 | $21,147,000 | 0.65% |
| Tygh Capital Management, Inc. | 64,127 | $4,003,000 | 0.54% |